Decoding Technological Advances in Biomanufacturing
Growing Viral Vector Contract Development Manufacturing Landscape
29-Jun-2020
Global
Technology Research
D99B-01-00-00-00
HC03315-GL-TR_24558
The rise in gene therapies over the last few years has created a huge opportunity for viral vector Contract Research Development Organization (CMO/CDMO) to fill the gap of high demand and shortage of viral vectors. As of January 2020, the US Food and Drug Administration FDA has approved four gene therapies and claims to have over 900 therapies in the pipeline. This creates a huge demand for viral vectors.
1.1 Key findings
1.2 Analysis Framework: Frost & Sullivan’s Core Value
1.3 Research Methodology
2.1 Advantages of Using Viral Vectors
2.2 Factors for Selection of Viral Vectors
2.3 Commonly used Viral Vectors
2.4 Suitable Scenario for Viral Vector Manufacturing
3.1Global Viral Vector Market
3.2 Challenges to Overcome
3.3 Increasing competition among viral vector CDMOs
3.4 Technology Adopted to Increase Production Rates
3.5 Mergers & Acquisitions
3.6 Research Collaborations
3.7 Long Term Collaborations
3.8 Recent Innovations at Viral Vector CDMOs
3.9 Digital Workflow Platforms
3.10 Recently Expanded Viral Vector BioManufacturing Units
3.11 Rising Trend of Expansion among Viral Vector CDMOs
3.12 Role of viral vector CDMO in COVID-19 scenario
3.13 Viral vector cdmos provide services for COVID-19 vaccine development
4.1 Innovation Radar of Viral Vector CDMOs
4.2 Summary of the Scoring Methodology
4.3 Advanced Bioscience Labs (ABL) Inc.
4.4 Batavia Bioscience
4.5 Biovian
4.6 CEVEC
4.7 Cobra Biologics
4.8 Oxford Genetics
4.9 Catalent
4.10 Molmed
4.11 Vigene
4.12 ProBiogen
4.13 Oxford Biomedica
4.14 Novasep
5.1 Growth Opportunity 1: R&D Investment
5.2 Growth Opportunity 2: Technology Convergence
5.3 Conclusion
6.1 IP Overview in Viral Vector Manufacturing
6.2 Leading Pharmaceutical Patent Holders
6.3 Top Patents in Viral Vector Modifications
6.4 Viral Vector Patents by Spark Therapeutics
6.5 Relevant Viral Vector Patents by University of Pennsylvania
7.1 Representation of Key Participants Based on Revenue
7.2 Key Industry Contacts
7.2 Key Industry Contacts
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.